Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A case of delivery of healthy infant in breast cancer patient incidentally treated with goserelin acetate and tamoxifen during pregnancy.

Ishizuka S, Satou S.

Breast Cancer. 2016 Jan;23(1):164-6. doi: 10.1007/s12282-013-0469-z. Epub 2013 May 1.

PMID:
23636905
2.

Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature.

Hill N, Madarnas Y.

Breast Cancer Res Treat. 2011 Aug;129(1):265-8. doi: 10.1007/s10549-011-1542-y. Epub 2011 May 4. Review.

PMID:
21541703
3.

Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.

Iwata H, Masuda N, Sagara Y, Kinoshita T, Nakamura S, Yanagita Y, Nishimura R, Iwase H, Kamigaki S, Takei H, Tsuda H, Hayashi N, Noguchi S.

Cancer. 2013 Feb 15;119(4):704-13. doi: 10.1002/cncr.27818. Epub 2012 Sep 12.

4.

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.

Sverrisdottir A, Johansson H, Johansson U, Bergh J, Rotstein S, Rutqvist L, Fornander T.

Breast Cancer Res Treat. 2011 Aug;128(3):755-63. doi: 10.1007/s10549-011-1593-0. Epub 2011 May 29.

PMID:
21625929
5.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
6.
7.

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.

Hackshaw A, Baum M, Fornander T, Nordenskjold B, Nicolucci A, Monson K, Forsyth S, Reczko K, Johansson U, Fohlin H, Valentini M, Sainsbury R.

J Natl Cancer Inst. 2009 Mar 4;101(5):341-9. doi: 10.1093/jnci/djn498. Epub 2009 Feb 24.

8.

[Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].

Asaga S, Ando J, Arai T, Fujii H.

Gan To Kagaku Ryoho. 2005 Jul;32(7):1069-72. Japanese.

PMID:
16044976
9.

[Sustained complete response in lung metastasis of breast cancer by goserelin--report of two cases].

Kuroi K, Tominaga T.

Gan To Kagaku Ryoho. 2002 Apr;29(4):589-94. Japanese.

PMID:
11977544
10.

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA, Beith J, Boyle F, Friedlander ML.

Lancet Oncol. 2005 Aug;6(8):581-8.

PMID:
16054569
11.

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

Davidson NE, O'Neill AM, Vukov AM, Osborne CK, Martino S, White DR, Abeloff MD.

J Clin Oncol. 2005 Sep 1;23(25):5973-82. Epub 2005 Aug 8.

PMID:
16087950
13.

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.

Sverrisdóttir A, Fornander T, Jacobsson H, von Schoultz E, Rutqvist LE.

J Clin Oncol. 2004 Sep 15;22(18):3694-9.

PMID:
15365065
14.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. doi: 10.1002/14651858.CD004562.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.

PMID:
18843661
15.

Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients.

Shimizu D, Ishikawa T, Tanabe M, Sasaki T, Ichikawa Y, Chishima T, Endo I.

Breast Cancer. 2014 Sep;21(5):557-62. doi: 10.1007/s12282-012-0429-z. Epub 2012 Nov 25.

PMID:
23184499
16.

Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms.

Nystedt M, Berglund G, Bolund C, Brandberg Y, Fornander T, Rutqvist LE.

Acta Oncol. 2000;39(8):959-68.

PMID:
11207003
17.

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.

Sverrisdottir A, Nystedt M, Johansson H, Fornander T.

Breast Cancer Res Treat. 2009 Oct;117(3):561-7. doi: 10.1007/s10549-009-0313-5. Epub 2009 Jan 20.

PMID:
19153828
18.

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.

International Breast Cancer Study Group (IBCSG), Castiglione-Gertsch M, O'Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD.

J Natl Cancer Inst. 2003 Dec 17;95(24):1833-46.

PMID:
14679153
19.

Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.

Kim HJ, Lee JS, Park EH, Lim WS, Sei JY, Koh BS, Son BH, Ahn JH, Jeong KH, Kim SB, Ahn SH.

Eur J Surg Oncol. 2009 Sep;35(9):936-41. doi: 10.1016/j.ejso.2009.01.016. Epub 2009 Mar 6.

PMID:
19269125
20.

[The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer].

Murtezani Z, Nešković-Konstantinović Z, Stanisavljević N, Kovčin V.

Srp Arh Celok Lek. 2011 May-Jun;139(5-6):339-46. Serbian.

Supplemental Content

Support Center